Status:

UNKNOWN

Respiratory Function in Patients With Post-tuberculosis Lung Impairment

Lead Sponsor:

Università degli Studi dell'Insubria

Collaborating Sponsors:

Fondazione Salvatore Maugeri

Azienda Ospedaliero Universitaria di Sassari

Conditions:

Lung Diseases, Obstructive

Pulmonary Rehabilitation

Eligibility:

All Genders

Phase:

NA

Brief Summary

Pulmonary tuberculosis (TB) is an important risk factor for chronic respiratory disease due to residual lung damage. A recent review of the literature on TB sequelae and rehabilitation has provided cl...

Detailed Description

Methods Respiratory functional parameters at baseline and at the end of the 15 sessions rehabilitation programme (RP) will be collected at the participating Centre. Follow-up visit 1 year after comple...

Eligibility Criteria

Inclusion

  • \- Patients with post-TB lung impairment after completion of pulmonary tuberculosis treatment - Patients with post- TB impairment after spontaneous healing

Exclusion

  • Any unstable medical condition
  • Musculoskeletal disorders contraindicating participation in the PR program
  • Cognitive impairment (Mini Mental State Examination \<22)
  • Unable to sign informed consent

Key Trial Info

Start Date :

February 14 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 14 2021

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03821285

Start Date

February 14 2019

End Date

January 14 2021

Last Update

January 29 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

ICS Maugeri, IRCCS

Tradate, Varese, Italy, 21049